Acquired Hemophilia Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1566702 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Acquired Hemophilia Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Acquired Hemophilia Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Acquired Hemophilia Treatment Overall Market Size
    2.1 Global Acquired Hemophilia Treatment Market Size: 2021 VS 2028
    2.2 Global Acquired Hemophilia Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Acquired Hemophilia Treatment Players in Global Market
    3.2 Top Global Acquired Hemophilia Treatment Companies Ranked by Revenue
    3.3 Global Acquired Hemophilia Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Acquired Hemophilia Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Acquired Hemophilia Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Acquired Hemophilia Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Acquired Hemophilia Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Acquired Hemophilia Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Acquired Hemophilia Treatment Market Size Markets, 2021 & 2028
        4.1.2 Traditional Therapy
        4.1.3 Advanced Therapy
    4.2 By Type - Global Acquired Hemophilia Treatment Revenue & Forecasts
        4.2.1 By Type - Global Acquired Hemophilia Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Acquired Hemophilia Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Acquired Hemophilia Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinic
        5.1.4 Others
    5.2 By Application - Global Acquired Hemophilia Treatment Revenue & Forecasts
        5.2.1 By Application - Global Acquired Hemophilia Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Acquired Hemophilia Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Acquired Hemophilia Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Acquired Hemophilia Treatment Revenue & Forecasts
        6.2.1 By Region - Global Acquired Hemophilia Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Acquired Hemophilia Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Acquired Hemophilia Treatment Revenue, 2017-2028
        6.3.2 US Acquired Hemophilia Treatment Market Size, 2017-2028
        6.3.3 Canada Acquired Hemophilia Treatment Market Size, 2017-2028
        6.3.4 Mexico Acquired Hemophilia Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Acquired Hemophilia Treatment Revenue, 2017-2028
        6.4.2 Germany Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.3 France Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.4 U.K. Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.5 Italy Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.6 Russia Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Acquired Hemophilia Treatment Market Size, 2017-2028
        6.4.8 Benelux Acquired Hemophilia Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Acquired Hemophilia Treatment Revenue, 2017-2028
        6.5.2 China Acquired Hemophilia Treatment Market Size, 2017-2028
        6.5.3 Japan Acquired Hemophilia Treatment Market Size, 2017-2028
        6.5.4 South Korea Acquired Hemophilia Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Acquired Hemophilia Treatment Market Size, 2017-2028
        6.5.6 India Acquired Hemophilia Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Acquired Hemophilia Treatment Revenue, 2017-2028
        6.6.2 Brazil Acquired Hemophilia Treatment Market Size, 2017-2028
        6.6.3 Argentina Acquired Hemophilia Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Acquired Hemophilia Treatment Revenue, 2017-2028
        6.7.2 Turkey Acquired Hemophilia Treatment Market Size, 2017-2028
        6.7.3 Israel Acquired Hemophilia Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Acquired Hemophilia Treatment Market Size, 2017-2028
        6.7.5 UAE Acquired Hemophilia Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Baxalta, Inc.
        7.1.1 Baxalta, Inc. Corporate Summary
        7.1.2 Baxalta, Inc. Business Overview
        7.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Major Product Offerings
        7.1.4 Baxalta, Inc. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.1.5 Baxalta, Inc. Key News
    7.2 Baxter Healthcare Corporation
        7.2.1 Baxter Healthcare Corporation Corporate Summary
        7.2.2 Baxter Healthcare Corporation Business Overview
        7.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Major Product Offerings
        7.2.4 Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.2.5 Baxter Healthcare Corporation Key News
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Corporate Summary
        7.3.2 Bristol-Myers Squibb Business Overview
        7.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Major Product Offerings
        7.3.4 Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.3.5 Bristol-Myers Squibb Key News
    7.4 Genentech, Inc.
        7.4.1 Genentech, Inc. Corporate Summary
        7.4.2 Genentech, Inc. Business Overview
        7.4.3 Genentech, Inc. Acquired Hemophilia Treatment Major Product Offerings
        7.4.4 Genentech, Inc. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.4.5 Genentech, Inc. Key News
    7.5 Novo Nordisk A/S
        7.5.1 Novo Nordisk A/S Corporate Summary
        7.5.2 Novo Nordisk A/S Business Overview
        7.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Major Product Offerings
        7.5.4 Novo Nordisk A/S Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.5.5 Novo Nordisk A/S Key News
    7.6 Ferring B.V.
        7.6.1 Ferring B.V. Corporate Summary
        7.6.2 Ferring B.V. Business Overview
        7.6.3 Ferring B.V. Acquired Hemophilia Treatment Major Product Offerings
        7.6.4 Ferring B.V. Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.6.5 Ferring B.V. Key News
    7.7 Sanofi SA
        7.7.1 Sanofi SA Corporate Summary
        7.7.2 Sanofi SA Business Overview
        7.7.3 Sanofi SA Acquired Hemophilia Treatment Major Product Offerings
        7.7.4 Sanofi SA Acquired Hemophilia Treatment Revenue in Global Market (2017-2022)
        7.7.5 Sanofi SA Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Acquired Hemophilia Treatment Market Opportunities & Trends in Global Market
    Table 2. Acquired Hemophilia Treatment Market Drivers in Global Market
    Table 3. Acquired Hemophilia Treatment Market Restraints in Global Market
    Table 4. Key Players of Acquired Hemophilia Treatment in Global Market
    Table 5. Top Acquired Hemophilia Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Acquired Hemophilia Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Acquired Hemophilia Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Acquired Hemophilia Treatment Product Type
    Table 9. List of Global Tier 1 Acquired Hemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Acquired Hemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Acquired Hemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Acquired Hemophilia Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Acquired Hemophilia Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Acquired Hemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Acquired Hemophilia Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Acquired Hemophilia Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Acquired Hemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Acquired Hemophilia Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Acquired Hemophilia Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Acquired Hemophilia Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Acquired Hemophilia Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Acquired Hemophilia Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Acquired Hemophilia Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Acquired Hemophilia Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Baxalta, Inc. Corporate Summary
    Table 31. Baxalta, Inc. Acquired Hemophilia Treatment Product Offerings
    Table 32. Baxalta, Inc. Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Baxter Healthcare Corporation Corporate Summary
    Table 34. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product Offerings
    Table 35. Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Bristol-Myers Squibb Corporate Summary
    Table 37. Bristol-Myers Squibb Acquired Hemophilia Treatment Product Offerings
    Table 38. Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. Genentech, Inc. Corporate Summary
    Table 40. Genentech, Inc. Acquired Hemophilia Treatment Product Offerings
    Table 41. Genentech, Inc. Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Novo Nordisk A/S Corporate Summary
    Table 43. Novo Nordisk A/S Acquired Hemophilia Treatment Product Offerings
    Table 44. Novo Nordisk A/S Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Ferring B.V. Corporate Summary
    Table 46. Ferring B.V. Acquired Hemophilia Treatment Product Offerings
    Table 47. Ferring B.V. Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. Sanofi SA Corporate Summary
    Table 49. Sanofi SA Acquired Hemophilia Treatment Product Offerings
    Table 50. Sanofi SA Acquired Hemophilia Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Acquired Hemophilia Treatment Segment by Type in 2021
    Figure 2. Acquired Hemophilia Treatment Segment by Application in 2021
    Figure 3. Global Acquired Hemophilia Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Acquired Hemophilia Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Acquired Hemophilia Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2021
    Figure 8. By Type - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 12. US Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 24. China Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Acquired Hemophilia Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Acquired Hemophilia Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Baxalta, Inc. Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Baxter Healthcare Corporation Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Bristol-Myers Squibb Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Genentech, Inc. Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Novo Nordisk A/S Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Ferring B.V. Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Sanofi SA Acquired Hemophilia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Acquired Hemophilia Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acquired Hemophilia Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acquired Hemophilia Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports